The short version of actin-binding motif fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-04. Anything still debated is marked as such rather than presented as settled.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
== Selected publications == Risk assessment of prenatally – induced adverse health effects. (with Neubert, Kavlock, and Klein, eds.), Springer – Verlag, Berlin et al., 1992. Anatomie für Anästhesisten, Blackwell – Wissenschaften, Berlin, 1990, ISBN 978-3894121013 Elektronenmikroskopischer Atlas, Blackwell – Wissenschaft, Berlin, 1989, ISBN 978-3894120542 Anatomie für medizinische Hilfsberufe, Walter de Gruyter, Berlin, 1989. Teratology of the limbs (co-editor), Walter de Gruyter – Verlag, Berlin, 1981. Culture techniques (with Neubert, eds.), Walter de Gruyter– Verlag, Berlin, 1981. Methods in prenatal toxicology (with Neubert and Kwasigroch, eds.), G. Thieme, Stuttgart, 1977.
== The Future Possibilities of Venomics == The field of venomics has been vastly revamped since its origin in the 20th century and continues to be improved with contemporary methods such as next generation sequencing and nuclear magnetic resonance spectroscopy. From this trend, it would seem that venomics will be progressively enhanced in its capabilities through the persistent technological advancements of the 21st century. As previously mentioned, a potential route that can be expanded upon further by venomics could be venom-specific molecules being co-opted into specialised medicines. The first example of this was in the early 1970s, when Captopril was found to be an inhibitor of angiotensin converting enzymes (ACE) and had the means of treating hypertension in people. Glenn King discusses the current state of venom-derived drugs, with six drugs derived from venom being FDA-approved and ten more currently being under clinical trials. Michael Pennington gives a detailed update on the current landscape of venom-derived drugs and the potential future of the field (Table 1). Anti-venoms is another branch of medicine, which needs to be improved due to the problems many developing countries face with venomous animals. Places like south/southeast Asia and sub-Saharan Africa are where many cases of both morbidity (limb amputation) and mortality take place.
=== Amygdala neurons === This theory hypothesizes that an early developmental failure involving the amygdala cascades on the development of cortical areas that mediate social perception in the visual domain. The fusiform face area of the ventral stream is implicated. The idea is that it is involved in social knowledge and social cognition, and that the deficits in this network are instrumental in causing autism.
Sources: en.wikipedia.org
Valve Corporation, also known as Valve Software, is an American video game developer, publisher, hardware, and digital distribution company headquartered in Bellevue, Washington. It is the developer of game franchises including Half-Life, Counter-Strike, Portal, Team Fortress, Left 4 Dead and Dota, the software service Steam, and hardware including the Steam Frame, Steam Machine, Steam Deck and Valve Index. Valve was founded in 1996 by former Microsoft employees Gabe Newell and Mike Harrington. Their debut game, the first-person shooter (FPS) Half-Life (1998), was a critical and commercial success that had a lasting influence on the genre. Harrington left in 2000. In 2003, Valve launched Steam, followed by Half-Life 2 (2004), the episodic sequels Half-Life 2: Episode One (2006) and Episode Two (2007), the puzzle games Portal (2007) and Portal 2 (2011), and the multiplayer games Team Fortress 2 (2007), Left 4 Dead (2008), and Dota 2 (2013). During the 2010s, Valve released fewer games and focused on hardware and virtual reality (VR). They released the first Steam Machine console in 2015, the Valve Index VR headset in 2019, their flagship VR game, Half-Life: Alyx, in 2020, and the handheld system Steam Deck in 2022. In 2026, Valve released a redesigned Steam Machine and a standalone VR headset, the Steam Frame. Valve uses a flat organizational structure, allowing employees to choose their own projects. Valve is noted for its technical and artistic innovation, with many of its games receiving mention among the greatest games of all time.
In July 2023, amid escalating tensions in the South China Sea, Chinese President Xi Jinping invited Duterte to Beijing. During the meeting, Xi asked Duterte to "play an important role" in improving Philippine-China relations, which were rapidly deteriorating under the Marcos administration that sought to gravitate towards the United States by expanding the number of bases American troops can access under the EDCA. As the meeting did not involve the Marcos administration, the event gained much attention, and the administration wanted details of the Xi-Duterte discussion. Duterte visited Malacanang Palace later and, in a closed-door session, discussed the matter with Marcos, though no further details were provided to the media.
=== Allied conferences, Polish governments === From the time of the Tehran Conference in late 1943, there was broad agreement among the three Great Powers (the United States, the United Kingdom, and the Soviet Union) that the locations of the borders between Germany and Poland and between Poland and the Soviet Union would be fundamentally changed after the conclusion of World War II. Stalin's view that Poland should be moved far to the west was accepted by Polish communists, whose organizations included the Polish Workers' Party and the Union of Polish Patriots. The communist-led State National Council, a quasi-parliamentary body, was in existence in Warsaw from the beginning of 1944. In July 1944, a communist-controlled Polish Committee of National Liberation was established in Lublin, to nominally govern the areas liberated from German control. The move prompted protests from Prime Minister Stanisław Mikołajczyk and his Polish government-in-exile. By the time of the Yalta Conference in February 1945, the communists had already established a Provisional Government of the Republic of Poland. The Soviet position at the conference was strong because of their decisive contribution to the war effort and as a result of their occupation of immense amounts of land in central and eastern Europe. The Great Powers gave assurances that the communist provisional government would be converted into an entity that would include democratic forces from within the country and active abroad, but the London-based government-in-exile was not mentioned.
Sources: en.wikipedia.org
U.S. Navy Fleet Admiral Hyman G. Rickover, nicknamed "Father of the Nuclear Navy", was forcibly retired four days after his 82nd birthday. Admiral Rickover's 63 years of active service in the U.S. Navy made him the longest-serving member of the U.S. armed forces. The fifth annual Charity Shield game of Australia's National Soccer League was played, matching the 1981 first-place finisher (Sydney City and the NSL Cup winner, the Brisbane Lions. Sydney City won, 3 to 1. Born: Marta Nieto, Spanish film and television actress known for the 2019 film Madre; in Murcia Jena Lee Nardella, American activist for clean water and ending AIDS in Africa; in Woodland, California Helena Paparizou, Swedish-born Greek singer; in Borås, Västergötland Died: Agnes Sligh Turnbull, 93, American novelist Kuljeet Singh and Jasbir Singha, convicted kidnappers and murderers who had killed two teenagers in India in 1978, were hanged at the Tihar Jail in New Delhi. Captain Cyril Gourley, 89, British Army officer and recipient of the Victoria Cross.
Nine variables were identified as effective predictors for 90-day mortality after a discharge from a cirrhosis-related hospital admission. The variables include all Model for End-Stage Liver Disease (MELD)'s components, as well as sodium, albumin, total cholesterol, white blood cell count, age, and length of stay. The hepatic venous pressure gradient (difference in venous pressure between incoming and outgoing blood to the liver) also determines the severity of cirrhosis, although it is hard to measure. A value of 16 mm or more means a greatly increased risk of death.
FS−SF → S=SF2 Decomposing to sulfur tetrafluoride and sulfur when heated to 180 °C: 2 S2F2 → SF4 + 3 S Hydrolysis: 2 S2F2 + 2 H2O → SO2 + 3 S + 4 HF Reacting with sulfuric acid at 80 °C: S2F2 + 3 H2SO4 → 5 SO2 + 2 HF + 2 H2O Reacting with sodium hydroxide: 2 S2F2 + 6 NaOH → Na2SO3 + 3 S + 4 NaF + 3 H2O Reacting with oxygen at high pressure, using nitrogen dioxide as a catalyst: 2 S2F2 + 5 O2 → SOF4 + 3 SO3
== Surgical procedure == TOPS is implanted following a lumbar decompression, in which bone and ligament tissue compressing the spinal nerves are removed. After decompression, the facet joints are excised and replaced with the TOPS implant. The goal is to preserve mobility at the treated level while preventing instability that would otherwise be addressed with spinal fusion.
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.